Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 6 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 12012597

    Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein

    ARIZ Precision Medicine, Inc. · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  2. US 12006522

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Precision BioSciences, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  3. US 11998516

    Methods and compositions for treating depression using cyclobenzaprine

    TONIX PHARMA LIMITED · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  4. US 11998520

    Methods for decreasing injuries associated with intraoperative hypotension

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  5. US 11993793

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Precision BioSciences, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  6. US 11987792

    Compositions and methods for inhibiting expression of the LECT2 gene

    Alnylam Pharmaceuticals, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  7. US 11981921

    TIL expansion processes using specific cytokine combinations and/or AKTi treatment

    Iovance Biotherapeutics, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  8. US 11981707

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2024 · Expires May 9, 2044

    granted
  9. US 11981897

    Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression

    Ionis Pharmaceuticals, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  10. US 11976309

    Fusion proteins and methods for site-directed genome editing

    The Regents of the University of California · Granted May 7, 2024 · Expires May 2, 2044

    granted
  11. US 11976126

    Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

    Inhibrx, Inc. · Granted May 7, 2024 · Expires May 2, 2044

    granted
  12. US 11969424

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    TENAX THERAPEUTICS, INC. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  13. US 11965017

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  14. US 11964010

    Prefusion coronavirus spike proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  15. US 11959080

    Methods and compositions for inhibiting PMP22 expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  16. US 11952429

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  17. US 11952402

    Fusion protein containing trail and IgG binding domain and the uses thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  18. US 11944679

    Genome-wide identification of immune evasion functions in a virus

    The Regents of the University of California · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  19. US 11946065

    Transgene cassettes, AAV vectors, and AAV viral vectors for expression of human codon-optimized CSTB

    The Board of Regents of the University of Texas System · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  20. US 11944666

    Treatment of inflammatory conditions delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  21. US 11939368

    QTY Fc fusion receptor proteins

    Avalon GloboCare Corp. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  22. US 11939367

    BTLA fusion protein agonists and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  23. US 11931453

    Drug delivery device

    Nano Precision Medical, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  24. US 11926825

    Compounds and methods for reducing ATXN2 expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted